Trial Profile
Clinical Trials Insight: 700021502
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 Mar 2007
Price :
$35
*
At a glance
- Drugs Anti-ferritin polyclonal antibody-Y-90 (Primary)
- Indications Hodgkin's disease
- Focus Adverse reactions
- Sponsors MABLife
- 09 Mar 2007 New trial record.